top of page

METABOLIC
MAGNETIC RESONANCE IMAGING

NVision Imaging is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

THIS IS POLARIS

Hyperpolarization enables rapid, precise measurement of natural metabolites by standard MRIs. NVision provides fast, robust, and easy-to-use hyperpolarization technology for preclinical and clinical research and clinical applications. Learn more

Polarizer_Shadow_Polaris.png

POLARIS OFFERS:

Nvision-Icon.png

High throughput (3min per dose)

Nvision-Icon.png

Convenient, room temperature processing

Nvision-Icon.png

Small footprint, no infrastructure adjustment

Nvision-Icon.png

Simple, robust workflow

Preorder Polaris for Preclinical application now
(delivery from early 2024)

METABOLIC MRI PROVIDES UNPRECEDENTED INSIGHTS AT CELLULAR LEVEL.

081722Brain-.png

vs

BRAIN-SEQUENCE-FINAL.gif

Standard MRI

Detects slow-changing effects at tissue level.

Metabolic MRI

Detects early changes of key metabolic pathways at cellular level.

WE HAVE DEVELOPED A UNIQUE QUANTUM-BASED PLATFORM THAT TRANSFORMS EXISTING MRIS INTO POWERFUL METABOLIC IMAGERS AT SCALE.

1

PREPARE

Drug Vial_NV LogoAND13C pyruvate precursor_WithoutBackground.png

Take precursor metabolic agent (natural to the body),

e.g., 13C-pyruvate

2

POLARIZE

Polarizer_Shadow_Polaris.png

Use POLARIS to rapidly enhance the MRI signal of the metabolic agent > 10,000x, making it visible to the MRI

3

SCAN

Free Standing MRI_V4.png

Inject the hyperpolarized metabolite and image with standard, i.e. existing MRI

METABOLIC MRI ADDS CRITICAL INFORMATION FOR ASSESSING TUMOROUS ACTIVITY AND VIABILITY BASED ON METABOLISM
IN LESS THAN 30 SECONDS.

Untitled-video-Made-with-Clipchamp-_1_.gif

METABOLIC INSIGHTS AT CELLULAR LEVEL ALLOW EARLIEST ASSESSMENT OF RESPONSE TO CANCER THERAPY.

CalendarMover.gif

vs

NVISION7DAYS.gif

Changes at tissue level:

Typically, changes are visible only months after onset of treatment.

Changes at cellular level:

Effective treatment induces metabolic response in tumor cells within days, visible with Metabolic MRI.

METABOLIC MRI FOR ADAPTIVE CANCER TREATMENT

Differentiation between resistant and sensitive tumors within days by means of Metabolic MRI: Patients who are found to have resistant tumors can shift to a combination therapy or alternate drug, whereas patients who are found to have sensitive tumors can confidently continue with the same treatment - but with certainty.

People_group.png
MRI.png
Pills.png
MRI.png
Differentiation.png
adjust.png

~ 7 days

PATIENT GROUP

METABOLIC MRI 

PRE-TREATMENT

TREATMENT

METABOLIC MRI

POST-TREATMENT

DIFFERENTIATION:

RESISTANT / SENSITIVE

ADJUSTED TREATMENT

Nvision-BG-Panels.jpg

HIGH IMPACT ACROSS MANY MEDICAL FIELDS - IN ONCOLOGY AND BEYOND

Website Icon - gray-06.jpg

Oncology

Copy of SquareGrey.png

Oncology
 

Treatment response assessment, early diagnosis and non-invasive assessment of tumor aggressiveness.

Cardiology.png

Cardiology

SquareGrey.png

Cardiology

Improved diagnosis and guidance of intervention in ischemic heart disease, and monitoring treatment response in heart failure patients.

Hepatology.png

Hepatology

SquareGrey.png

Hepatology

Early diagnosis and treatment response assessment for nonalcoholic steatohepatitis (NASH).

Nephrology.png

Nephrology

SquareGrey.png

Nephrology

Assessment of etiology and treatment response in chronic and acute kidney failure.

Neurology.png

Neurology

SquareGrey.png

Neurology

Early diagnosis and treatment response assessment over a wide range of neurodegenerative, inflammatory, ischemic, and traumatic conditions.

Rheumatology.png

Rheumatology

SquareGrey.png

Rheumatology

Early diagnosis and treatment response assessment for inflammatory arthritis and other inflammatory conditions.

THE TEAM

Nvision-Team-Photo.png

FOUNDING TEAM

Sella_1.jpg

Sella Brosh, M.D. 
Chief Executive Officer

Ilai Schwartz.jpg

Dr. Ilai Schwartz
Co-Founder & CTO

Martin Plenio.jpg
Fedor Jelezko_V2.jpg
Alex Retzker.jpg
Contact Form

INVESTORS

NVision is funded by deep-tech investors and highly-competitive grants,
collaborating with top-tier medical and research units in US and EU

BTOV.png
Logo_Pathena-01.png

Lauder

Contact Form

FOR MORE INFORMATION
CONNECT WITH US

arrow&v

Thanks for submitting!

FEATURES IN LEADING JOURNALS
AND PRESS RELEASES

nVISION_FEATURES.png
nVISION_FEATURES.png
nVISION_FEATURES.png
nVISION_FEATURES.png
ScienceLogo1.jpg
bottom of page